Social media fuels enthusiasm for new weight-loss drugs. Are regulators watching?

Online platforms are overflowing with testimonials for GLP-1s. The drugs show promise for inducing weight loss, but many aren’t FDA-approved for that use.

Related Keywords

Washington ,United States ,New York ,New Jersey ,Chicago ,Illinois ,United Kingdom ,Australia ,Georgetown University ,District Of Columbia ,Australian ,Americans ,Elizabeth Wassenaar ,Novo Nordisk Ozempic ,Chelsea Handler ,Samantha Klecyngier ,Eli Lilly Mounjaro ,Michael Albert ,Jeremy Kahn ,Priya Jaisinghani ,Juliana Simonetti ,Novo Nordisk Wegovy ,Judy Butler ,Allison Schneider ,Remi Bader ,Suzette Zuena ,University Of Utah ,Instagram ,Health Care Providers ,Health News ,Georgetown University Medical Center ,York University Grossman School Of Medicine ,Facebook ,Novo Nordisk ,Recovery Center ,Morgan Stanley ,New York University ,Grossman School ,Eli Lilly ,Federal Trade Commission ,Eating Recovery Center ,Compounding Spark Excitement ,Accomplish Health ,Health Care ,Weight Loss ,New York City ,